Victory Capital Management’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-69,102
| Closed | -$27.5K | – | 2730 |
|
|
2022
Q4 | $27.5K | Sell |
69,102
-5,336
| -7% | -$2.12K | ﹤0.01% | 2498 |
|
|
2022
Q3 | $58K | Sell |
74,438
-24
| -0% | -$19 | ﹤0.01% | 2551 |
|
|
2022
Q2 | $214K | Sell |
74,462
-121,972
| -62% | -$351K | ﹤0.01% | 2333 |
|
|
2022
Q1 | $985K | Sell |
196,434
-14,226
| -7% | -$71.3K | ﹤0.01% | 1822 |
|
|
2021
Q4 | $2.35M | Sell |
210,660
-18,091
| -8% | -$202K | ﹤0.01% | 1506 |
|
|
2021
Q3 | $3.74M | Sell |
228,751
-1,429
| -0.6% | -$23.3K | ﹤0.01% | 1407 |
|
|
2021
Q2 | $4.27M | Sell |
230,180
-44,280
| -16% | -$821K | ﹤0.01% | 1395 |
|
|
2021
Q1 | $4.14M | Buy |
274,460
+180,157
| +191% | +$2.72M | ﹤0.01% | 1410 |
|
|
2020
Q4 | $3.05M | Buy |
+94,303
| New | +$3.05M | ﹤0.01% | 1378 |
|